KRBP
Kiromic BioPharma Inc

2,429
Mkt Cap
$3.00
Volume
6,255.00
52W High
$1.60
52W Low
$0.00
PE Ratio
0.00
KRBP Fundamentals
Price
$0.00
Prev Close
$0.0001
50D MA
$0.00
Beta
23.71
Avg. Volume
184.15
EPS (Annual)
-$23.09
P/B
0.00
Rev/Employee
$0.00
$14.09
Loading...
Loading...

About

Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers. The company was founded by Maurizio Chiriva-Internati and Scott Dahlbeck on August 6, 2006 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
44

Frequently Asked Questions

What is Market Cap of Kiromic BioPharma Inc?
What is the 52-week high for Kiromic BioPharma Inc?
What was Kiromic BioPharma Inc stock price yesterday?
How many employees does Kiromic BioPharma Inc have?

Latest KRBP News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.